0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > Pleiotrophin

Pleiotrophin

Brief Information

Name:Angiopoietin-related protein 4
Target Synonym:Angiopoietin-like protein 4,Hepatic fibrinogen/angiopoietin-related protein,HFARP,ARP4,PGAR,PP1158,PSEC0166,UNQ171/PRO197,Angiopoietin Like 4,Hepatic Fibrinogen/Angiopoietin-Related Protein,Angiopoietin-Related Protein 4,Pp1158,FIAF,NL2,Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein,Hepatic Angiopoietin-Related Protein,PPARG Angiopoietin Related Protein,Fasting-Induced Adipose Factor,Angiopoietin-Like Protein 4,Angiopoietin-Like 4,UNQ171,TGQTL,HARP
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Nach Produktstatus:
Nach Produktkategorie :
Nach Arten:
Nach Markierungen:
Nach Konjugaten:
Kat. Nr. Arten Produktbeschreibung Struktur Reinheit Merkmal
PLN-H5244 Human Human Pleiotrophin / PTN Protein, His Tag, premium grade
PLN-H5244-structure
PLN-H5244-sds
ACRO Quality

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Lipisense Phase 1 Clinical Lipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KG Hypertriglyceridemia Details
Lipisense Phase 1 Clinical Lipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KG Hypertriglyceridemia Details

This web search service is supported by Google Inc.

totop

Nachricht schicken